Etomidate vs. Midazolam for Sedation During ERCP

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
Recently up-coming drug, etomidate which is a modulator of GABA(gamma-Aminobutyric acid)-A receptor has been known that it maintains the appropriate sedative levels and affects little effects on respiratory system. The investigators are now trying to investigate that etomidate with meperidine combination regimen is superior to the midazolam with meperidine more effective and less harm on sedation during the ERCP procedure.
Epistemonikos ID: 212993b97f9e00d3b55cc8f392473abfc8cb8c3f
First added on: May 11, 2024